Relmada Therapeutics, Inc. · NASDAQ:RLMD
Ikarian Capital, LLC's stake in Relmada Therapeutics, Inc. fell to 4.80% (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Ikarian Capital, LLC's stake in Relmada Therapeutics, Inc. fell to 4.80%, 3,543,359 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 4.80%
- Shares
- 3,543,359
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 4.80% | 3,543,359 |
| Neil Shahrestani | 4.80% | 3,543,359 |
Source
Related
- Relmada Therapeutics, Inc.
- Ikarian Capital, LLC
- Relmada Therapeutics, Inc. shareholders
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026